Collection
Clinical trial perspectives
- Submission status
- Open
- Open for submission from
- 01 January 2020
- Submission deadline
- Ongoing
Expert authored perspectives of clinical trials
Articles (7 in this collection)
-
-
The Role of Tirzepatide, Dual GIP and GLP-1 Receptor Agonist, in the Management of Type 2 Diabetes: The SURPASS Clinical Trials
Authors
- Thinzar Min
- Stephen C. Bain
- Content type: Review
- Open Access
- Published: 15 December 2020
- Pages: 143 - 157
-
Sodium-Glucose Co-Transporter 2 (SGLT2) Inhibitors: Are They All the Same? A Narrative Review of Cardiovascular Outcome Trials
Authors
- David M. Williams
- Asif Nawaz
- Marc Evans
- Content type: Review
- Open Access
- Published: 13 November 2020
- Pages: 55 - 70
-
Insights from VERIFY: Early Combination Therapy Provides Better Glycaemic Durability Than a Stepwise Approach in Newly Diagnosed Type 2 Diabetes
Authors (first, second and last of 8)
- David Matthews
- Stefano Del Prato
- Päivi Maria Paldánius
- Content type: Commentary
- Open Access
- Published: 25 September 2020
- Pages: 2465 - 2476
-
Semaglutide: Charting New Horizons in GLP-1 Analogue Outcome Studies
Authors
- David M. Williams
- Marc Evans
- Content type: Review
- Open Access
- Published: 03 September 2020
- Pages: 2221 - 2235
-
Dapagliflozin for Heart Failure with Preserved Ejection Fraction: Will the DELIVER Study Deliver?
Authors
- David M. Williams
- Marc Evans
- Content type: Review
- Open Access
- Published: 27 August 2020
- Pages: 2207 - 2219
-
Are SGLT-2 Inhibitors the Future of Heart Failure Treatment? The EMPEROR-Preserved and EMPEROR-Reduced Trials
Authors
- David M. Williams
- Marc Evans
- Content type: Review
- Open Access
- Published: 24 July 2020
- Pages: 1925 - 1934